Guangdong, China

Hekun Zeng

This inventor holds 1 USPTO granted patent. Top assignee: Jinan University. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hekun Zeng in Sustained-Release Microgel Ointments

Introduction

Hekun Zeng is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release microgel ointments. His innovative approach focuses on enhancing drug loading and improving the efficacy of topical treatments.

Latest Patents

Hekun Zeng holds a patent for "Sustained-release microgel ointments with high drug loading and preparation methods and uses thereof." This patent discloses a method for creating a sustained-release microgel ointment that combines HTCC and HA aqueous solutions. The resulting microgel is designed to safely and effectively deliver drugs through the skin. The unique formulation allows for a higher concentration of the drug, which prolongs the release time and enhances therapeutic effects.

Career Highlights

Hekun Zeng is affiliated with Jinan University, where he conducts research and development in pharmaceutical sciences. His work has led to advancements in drug delivery systems, particularly for treating conditions such as histamine-independent pruritus and analgesia. His innovative methods have the potential to reduce costs and improve patient outcomes.

Collaborations

Hekun Zeng has collaborated with colleagues such as Hong Nie and Jianhao Zhao. Their combined expertise contributes to the ongoing research and development of effective pharmaceutical solutions.

Conclusion

Hekun Zeng's contributions to the field of sustained-release microgel ointments demonstrate his commitment to innovation in drug delivery systems. His work not only enhances the efficacy of treatments but also aims to make them more accessible and cost-effective for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…